Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Nov 17;22(22):12379.
doi: 10.3390/ijms222212379.

COX Inhibitory and Cytotoxic Naphthoketal-Bearing Polyketides from Sparticola junci

Affiliations

COX Inhibitory and Cytotoxic Naphthoketal-Bearing Polyketides from Sparticola junci

Katherine Yasmin M Garcia et al. Int J Mol Sci. .

Abstract

Axenic fermentation on solid rice of the saprobic fungus Sparticola junci afforded two new highly oxidized naphthalenoid polyketide derivatives, sparticatechol A (1) and sparticolin H (2) along with sparticolin A (3). The structures of 1 and 2 were elucidated on the basis of their NMR and HR-ESIMS spectroscopic data. Assignment of absolute configurations was performed using electronic circular dichroism (ECD) experiments and Time-Dependent Density Functional Theory (TDDFT) calculations. Compounds 1-3 were evaluated for COX inhibitory, antiproliferative, cytotoxic and antimicrobial activities. Compounds 1 and 2 exhibited strong inhibitory activities against COX-1 and COX-2. Molecular docking analysis of 1 conferred favorable binding against COX-2. Sparticolin H (2) and A (3) showed a moderate antiproliferative effect against myelogenous leukemia K-562 cells and weak cytotoxicity against HeLa and mouse fibroblast cells.

Keywords: COX inhibitory; ECD-TDDFT; Sparticola junci; antiproliferative; cytotoxic; molecular docking; structure elucidation.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Dioxynaphthalenoids 1–3 from Sparticola junci.
Figure 2
Figure 2
COSY and HMBC correlations in 1 and 2.
Figure 3
Figure 3
Experimental ECD spectrum of sparticatechol A (1, black solid curve) compared with B3LYP/6-31G(d)-calculated ECD spectra (red solid curve) for the B3LYP/6-31G(d)-optimized conformers of (8S,22R)-1.
Figure 4
Figure 4
Experimental ECD spectrum of sparticolin H (2, black solid curve) compared with WB97XD/DGDZVP (PCM/MeCN)-calculated ECD spectra (red solid curve) for the WB97XD/DGDZVP-optimized conformers of (4S,5S,7R)-2.
Figure 5
Figure 5
3D and 2D docked poses of sparticatechol A (1) against (A) COX-2 (PDB ID: 3LN1) and (B) COX-1 (PDB ID: 3KK6).
Figure 6
Figure 6
Prediction of GI tract and brain permeation of compounds 13 by brain or the intestinal estimated permeation predictive model (BOILED-Egg) method.

Similar articles

Cited by

References

    1. Kuephadungphan W., Macabeo A.P.G., Luangsa-ard J.J., Stadler M. Discovery of novel biologically active secondary metabolites from Thai mycodiversity with anti-infective potential. CRBIOT. 2004;3:160–172. doi: 10.1016/j.crbiot.2021.05.003. - DOI
    1. Hyde K.D., Xu J., Rapior S., Jeewon R., Lumyong S., Niego A.G.T., Abeywickrama P.D., Aluthmuhandiram J.V.S., Brahamanage R.S., Brooks S., et al. The amazing potential of fungi: 50 ways we can exploit fungi industrially. Fungal Divers. 2019;97:1–136.
    1. Bills G.F., Gloer J.B. Biologically active secondary metabolites from the fungi. Microbiol. Spectr. 2016;4:1–32. doi: 10.1128/microbiolspec.FUNK-0009-2016. - DOI - PubMed
    1. Cai Y.-S., Guo Y.-W., Krohn K. Structure, bioactivities, biosynthetic relationships and chemical synthesis of the spirodioxynaphthalenes. Nat. Prod. Rep. 2010;27:1840–1870. doi: 10.1039/c0np00031k. - DOI - PubMed
    1. Ogishi H., Chiba N., Mikawa T., Sasaki T., Miyaji S., Sezaki M. Mitsubishi Kasei Corp., JP 01294686. Chem. Abstr. 1990;113:38906q.

MeSH terms

Supplementary concepts

LinkOut - more resources